Additionally, mutational variants of EGFR, KRAS, and PIK3CA genes are identified by CTCs sequencing in patients with colorectal cancer, which are associated with therapeutic response to EGFR-targeted therapy in patients [60]. The gene discussed is KRAS; the disease is colorectal cancer.